| Literature DB >> 25050127 |
Ran Li1, Li Jin2, Ping Hong1, Zi-Hong He1, Chuan-Ye Huang1, Jie-Xiu Zhao1, Mei Wang1, Ye Tian1.
Abstract
The purpose of study was to assess the efficacy of a 16-week Baduanjin qigong training intervention in promoting physical fitness and health for adults. An experimental design was adopted, and subjects were assigned randomly into an experimental group (n = 55) and a control group (n = 55). In the intervention group comprised of adults, there were no significant variations in blood glucose, blood lipid, blood pressure, heart rate variability, and vital capacity indices. The body weight and body mass index (BMI) dropped in the intervention group. Compared with the control group, the skinfold thicknesses decreased at lower corner of scapula, triceps brachii, and abdomen, with a statistical significance (P < 0.001; P = 0.005; P = 0.003). By comparing the physical fitness indices, it was found that the increase of the results of sit-and-reach test in the intervention group had statistical significance (P = 0.001). In conclusion, it was found by our trial that Baduanjin exercise could significantly improve the physical flexibility and subcutaneous adipose accumulation in the healthy adults.Entities:
Year: 2014 PMID: 25050127 PMCID: PMC4094699 DOI: 10.1155/2014/784059
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
The data of the preliminary experiment.
| Characteristic | Mean | SD | Sample size |
|---|---|---|---|
| Weight (kg) | 59.3 | 10.8 | 22 |
| Waist (cm) | 78.5 | 8.1 | 7 |
| Inferior angle of the scapula (mm) | 21.1 | 5.1 | 40 |
| Triceps (mm) | 19.7 | 5.0 | 44 |
| Abdomen (mm) | 26.9 | 6.1 | 35 |
| Systolic (mmHg) | 108.4 | 14.3 | 12 |
| Diastolic (mmHg) | 68.4 | 9.2 | 13 |
| VC (mL) | 3178 | 579 | 22 |
| FVC (L) | 2.8 | 0.7 | 42 |
| Mean R-R (ms) | 854.3 | 243 | 55 |
| SR (cm) | 11.9 | 3.3 | 52 |
| VO2max (mL/kg | 28.3 | 5.5 | 25 |
Figure 1The flow of participants through the trial.
Baseline characteristics of participants in intervention and control groups.
| Characteristic | Intervention | Control |
|
|
|---|---|---|---|---|
| Male | 17 | 19 | 0.420# | |
| Female | 38 | 36 | ||
| Age | 35.5 (16.0) | 32.9 (13.0) | 0.944 | 0.347∗ |
| BMI | 23.2 (3.3) | 22.5 (3.1) | 1.162 | 0.248∗ |
| TG (mmol/L) | 1.06 (0.58) | 1.11 (0.96) | −0.337 | 0.737∗ |
| TC (mmol/L) | 4.54 (0.99) | 4.30 (0.82) | 1.372 | 0.173∗ |
| LDL (mmol/L) | 2.86 (0.86) | 2.62 (0.72) | 1.513 | 0.133∗ |
| HDL (mmol/L) | 1.59 (0.40) | 1.54 (0.35) | 0.688 | 0.493∗ |
| Weight (kg) | 63.5 (11.2) | 61.4 (11.8) | 0.939 | 0.350∗ |
| Chest (cm) | 89.9 (7.7) | 88.8 (8.0) | 0.683 | 0.496∗ |
| Waist (cm) | 83.1 (10.1) | 79.9 (10.6) | 1.580 | 0.117∗ |
| Hip (cm) | 94.8 (7.4) | 94.5 (5.7) | 0.276 | 0.783∗ |
| Inferior angle of the scapula (mm) | 17.7 (5.0) | 16.2 (4.9) | 1.632 | 0.106∗ |
| Triceps (mm) | 17.0 (6.2) | 15.4 (5.0) | 1.511 | 0.134∗ |
| Abdomen (mm) | 19.2 (5.8) | 16.4 (5.4) | 2.568 | 0.012∗ |
| Systolic (mmHg) | 117.3 (12.3) | 114.4 (13.3) | 1.079 | 0.284∗ |
| Diastolic (mmHg) | 75.4 (8.8) | 71.0 (8.7) | 2.335 | 0.022∗ |
| Mean R-R (ms) | 857.1 (114.4) | 827.1 (134.4) | 1.256 | 0.212∗ |
| LF% | 47.2 (22.6) | 45.8 (20.7) | 0.326 | 0.745∗ |
| HF% | 172.0 (905.1) | 54.6 (20.4) | 0.961 | 0.339∗ |
| LF/HF | 1.5 (1.7) | 1.4 (2.0) | 0.105 | 0.917∗ |
| VC (L) | 3,091.6 (1,011.4) | 3,120.4 (791.4) | −0.163 | 0.871∗ |
| FVC (L) | 3.1 (1.0) | 3.1 (0.8) | −0.145 | 0.885∗ |
| FEV1 (L) | 3.0 (1.0) | 2.8 (0.7) | 0.641 | 0.523∗ |
| FEV1% | 90.8 (6.8) | 87.5 (15.6) | 1.360 | 0.177∗ |
| PEF (L/s) | 5.9 (2.0) | 6.1 (2.1) | −0.366 | 0.715∗ |
| PET (s) | 1.5 (0.5) | 1.8 (1.1) | −1.819 | 0.072∗ |
| SR (cm) | 15.3 (8.7) | 13.1 (11.2) | 1.171 | 0.244∗ |
| ES (s) | 39.8 (57.7) | 29.4 (24.0) | 1.211 | 0.229∗ |
|
VO2max (mL/kg | 28.9 (10.4) | 27.7 (7.7) | 0.688 | 0.493∗ |
| HRmax (1/min) | 161.1 (32.9) | 170.1 (18.7) | −1.744 | 0.084∗ |
| VEmax (L/min) | 60.9 (28.9) | 56.7 (15.5) | 0.946 | 0.346∗ |
| SDS | 41.5 (11.1) | 47.9 (12.0) | −2.900 | 0.005∗ |
#The chi-square test was used to examine the homogeneity. ∗The t-test was used to examine the homogeneity.
Comparison of blood lipid indices.
| Characteristic | Baseline | Follow-up | Posttest-pretest scores | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intervention | Control | Intervention | Control | Intervention-control | |||||||||
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | 95% CI |
|
| ||
| TG (mmol/L) | 1.05 | 0.57 | 1.11 | 0.96 | 1.20 | 0.54 | 1.26 | 0.83 | −0.07 | −0.26 | 0.12 | −0.713 | 0.478 |
| TC (mmol/L) | 4.65 | 1.01 | 4.30 | 0.82 | 4.23 | 0.96 | 4.12 | 0.97 | −0.21 | −0.49 | 0.07 | −1.460 | 0.148 |
| LDL (mmol/L) | 2.91 | 0.89 | 2.62 | 0.72 | 2.39 | 0.80 | 2.30 | 0.74 | −0.14 | −0.37 | 0.10 | −1.170 | 0.245 |
| HDL (mmol/L) | 1.66 | 0.40 | 1.54 | 0.35 | 1.54 | 0.38 | 1.50 | 0.35 | −0.09 | −0.18 | 0.01 | −1.779 | 0.079 |
Comparison of body function indices.
| Characteristic | Baseline | Follow-up | Posttest-pretest scores | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intervention | Control | Intervention | Control | Intervention-control | |||||||||
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | 95% CI |
|
| ||
| Systolic (mmHg) | 113.0 | 7.2 | 111.0 | 10.5 | 110.4 | 8.8 | 111.0 | 10.0 | −0.4 | −6.3 | 5.6 | −0.119 | 0.905 |
| Diastolic (mmHg) | 73.8 | 7.4 | 70.6 | 8.3 | 72.3 | 8.9 | 74.9 | 6.9 | −4.7 | −9.3 | −0.1 | −2.015 | 0.048 |
| Mean R-R (ms) | 860.2 | 115.3 | 827.1 | 134.4 | 851.4 | 121.2 | 815.9 | 135.7 | 2.4 | −53.5 | 58.4 | 0.086 | 0.931 |
| LF% | 48.6 | 19.4 | 45.8 | 20.7 | 52.2 | 18.0 | 52.7 | 21.1 | −3.2 | −13.8 | 7.5 | −0.588 | 0.558 |
| HF% | 51.0 | 19.5 | 54.6 | 20.4 | 47.9 | 17.9 | 47.3 | 21.1 | 4.4 | −6.2 | 15.1 | 0.827 | 0.411 |
| LF/HF | 1.5 | 1.7 | 1.4 | 2.0 | 1.6 | 1.5 | 1.7 | 1.4 | −0.2 | −1.1 | 0.7 | −0.434 | 0.666 |
| VC (L) | 2897.4 | 914.4 | 3120.4 | 791.4 | 2996.9 | 987.3 | 3192.7 | 686.6 | 53.7 | −84.1 | 191.5 | 0.774 | 0.441 |
| FVC (L) | 2.9 | 0.9 | 3.1 | 0.8 | 2.9 | 0.9 | 3.1 | 0.6 | 0.0 | −0.2 | 0.2 | −0.060 | 0.952 |
| FEV1 (L) | 2.8 | 0.9 | 2.8 | 0.7 | 2.6 | 0.9 | 2.7 | 0.6 | −0.1 | −0.3 | 0.1 | −0.873 | 0.385 |
| FEV1% | 90.6 | 7.4 | 90.1 | 6.6 | 87.8 | 10.6 | 85.7 | 10.3 | −0.6 | −4.7 | 3.5 | −0.280 | 0.780 |
| PEF (L/s) | 5.6 | 1.8 | 6.1 | 2.1 | 4.9 | 1.8 | 5.2 | 2.3 | 0.3 | −0.3 | 0.9 | 0.910 | 0.365 |
| PET (s) | 1.5 | 0.5 | 1.8 | 1.1 | 1.7 | 0.6 | 1.9 | 0.7 | 0.1 | −0.2 | 0.5 | 0.876 | 0.383 |
Comparison of body shape indices.
| Characteristic | Baseline | Follow-up | Posttest-pretest scores | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intervention | Control | Intervention | Control | Intervention-control | |||||||||
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | 95% CI |
|
| ||
| Weight (kg) | 61.1 | 9.2 | 61.4 | 11.8 | 59.2 | 9.0 | 60.3 | 11.7 | −0.5 | −1.2 | 0.2 | −1.453 | 0.150 |
| BMI | 22.8 | 2.9 | 22.5 | 3.1 | 22.0 | 2.6 | 22.0 | 3.2 | −0.2 | −0.7 | 0.4 | −0.595 | 0.554 |
| Chest (cm) | 88.8 | 6.8 | 88.8 | 8.0 | 89.0 | 6.7 | 88.7 | 12.4 | 0.2 | −1.1 | 4.9 | 1.288 | 0.201 |
| Waist (cm) | 82.1 | 9.7 | 79.9 | 10.6 | 83.3 | 9.1 | 83.8 | 9.3 | 0.8 | −3.0 | 2.3 | −0.287 | 0.775 |
| Hip (cm) | 94.8 | 5.7 | 94.5 | 5.7 | 94.2 | 5.2 | 95.7 | 5.3 | −1.2 | −2.5 | 0.2 | −1.688 | 0.095 |
| Inferior angle of the scapula (mm) | 18.0 | 4.9 | 16.2 | 4.9 | 14.3 | 3.8 | 17.0 | 6.6 | −4.0 | −6.0 | −1.9 | −3.887 | 0.000 |
| Triceps (mm) | 18.1 | 6.1 | 15.4 | 5.1 | 14.7 | 4.1 | 15.3 | 5.2 | −3.4 | −5.7 | −1.1 | −2.894 | 0.005 |
| Abdomen (mm) | 19.5 | 5.4 | 16.4 | 5.4 | 19.9 | 5.5 | 20.3 | 7.3 | −3.3 | −5.4 | −1.2 | −3.092 | 0.003 |
Comparison of physical fitness indices.
| Characteristic | Baseline | Follow-up | Posttest-pretest scores | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intervention | Control | Intervention | Control | Intervention-control | |||||||||
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | 95% CI |
|
| ||
| SR (cm) | 15.3 | 8.1 | 12.7 | 8.7 | 17.3 | 8.6 | 12.9 | 8.1 | 3.5 | 1.5 | 5.5 | 3.464 | 0.001 |
| ES (s) | 31.1 | 28.7 | 29.4 | 24.0 | 43.7 | 43.1 | 43.8 | 37.3 | −21.1 | −46.9 | 4.6 | −1.630 | 0.106 |
| VO2max (mL/kg | 27.8 | 10.2 | 27.7 | 7.7 | 29.3 | 11.8 | 28.1 | 8.1 | 1.1 | −2.2 | 4.4 | 0.658 | 0.512 |
| HRmax (1/min) | 161.8 | 27.1 | 170.1 | 18.7 | 162.4 | 24.3 | 163.8 | 21.2 | 6.9 | 0.2 | 13.5 | 2.031 | 0.045 |
| VEmax (L/min) | 52.4 | 22.4 | 56.7 | 15.7 | 56.8 | 22.6 | 56.0 | 16.3 | 5.2 | −0.2 | 10.6 | 1.913 | 0.059 |
Comparison of scores from self-rating depression scale (SDS).
| Characteristic | Baseline | Follow-up | Posttest-pretest scores | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intervention | Control | Intervention | Control | Intervention-control | |||||||||
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | 95% CI |
|
| ||
| SDS | 34.1 | 9.3 | 39.9 | 10 | 37.1 | 9.1 | 40.7 | 11 | 2.07 | −3.34 | 7.48 | 0.759 | 0.450 |